Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned MONTVALE, N. J., Jan. 07, 2026 (GLOBE ...
Eye specialists are urging citizens to undergo regular retina examinations to prevent long-term vision problems, citing a rise in retinal disorders among adults and seniors. Retina, the ...
Dr Sunir Garg reflects on the recent American Academy of Ophthalmology meeting in Orlando and expresses excitement on how artificial intelligence (AI) can be used to detect, treat, and transform the ...
Using data from the FDA Adverse Event Reporting System, researchers investigated the prevalence of pentosan polysulfate sodium–associated retinal disorders. Results of a disproportionality analysis ...
Every last Sunday of September marks World Retinitis Pigmentosa (RP) Day, a day dedicated to raising awareness and accelerating efforts to find a cure for this rare, inherited retinal disease ...
Sunir Garg, MD, expresses excitement about attending AAO 2025 and focuses on several topics to be discussed. These include the benefits and potential vision risks of GLP-1 inhibitors in patients with ...
The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully replicates the structural layers and microvascular network of the human ...
Population-based studies have shown retinal disorders are the most common cause of irreversible blindness in developed countries and the second most common cause of blindness after cataracts in ...
In a study funded by the National Institutes of Health, researchers at Brown University suggest that gold nanoparticles (microscopic gold particles thousands of times thinner than a human hair) could ...
Human eyes, like a fingerprint, are unique. They can say so much without saying a word. They can communicate our needs, desires, fears, and so much more. Our eyes can reveal a lot about us as ...
Less than 30% of people with certain genetic variants go blind, despite the faulty genes previously being thought to cause ...
EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”) an innovative biotechnology company focused on developing transformative treatments for chronic inflammatory conditions and debilitating retinal ...